Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Bronchoscopy | Research article

Long-term prognostic factors of clinical success after interventional bronchoscopy in patients with scarring central airway stenosis

Authors: Kunyan Sun, Hong Zhang, Wei Zhang, Yuan Cheng, Guangfa Wang

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Scarring central airway stenosis (SCAS) is a potentially life-threatening condition with debilitating symptoms. Interventional bronchoscopy is increasingly used to relieve symptoms in patients with SCAS, but recurrent stenosis is frequently observed. Little data exist on the long-term prognosis of interventional bronchoscopy for SCAS. We aimed to assess the prognostic factors of bronchoscopic interventions in patients with SCAS to optimize treatment.

Methods

This was a retrospective study that enrolled 119 consecutive patients with SCAS from January 2010 to April 2019 at our institution. Long-term clinical success was defined as airway stenosis < 50%, no limitation of physical activity, and a stable condition for > 12 months after the last interventional procedure. We compared patients’ demographics, airway stenosis characteristics, and interventional procedures between the successful and unsuccessful groups, and identified significant predictors of long-term outcome with univariate and multivariate logistic regression.

Results

A total of 119 patients with 577 therapeutic bronchoscopies were included. Seventy-five (63%) patients were considered to have long-term clinical success. Older age, male gender, smoking, elevated C-reactive protein level, subglottic stenosis, stent or T-tube implantation, previous interventional treatment, and multiple procedures per year were potentially associated with unsuccessful long-term outcomes in the univariate analysis. Current smoker status (odds ratio [OR] 5.70, 95% confidence interval [CI] 1.35–24.17, P = 0.018), subglottic stenosis (OR 4.35, 95% CI 1.31–14.46, P = 0.017), and stent implantation (OR 4.96, 95% CI 1.33–18.48, P = 0.017) were associated with decreased odds of long-term success in the multivariate logistic regression analysis. Of note, there was no significant difference in odds of success between former smokers and nonsmokers.

Conclusions

Current smoker status, subglottic stenosis, and stent implantation are independent factors associated with reduced long-term efficacy of interventional bronchoscopy for SCAS. Smoking cessation should be encouraged to improve the outcome of therapeutic bronchoscopy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Freitag L, Ernst A, Unger M, et al. A proposed classification system of central airway stenosis. Eur Respir J. 2007;30:7–12.CrossRef Freitag L, Ernst A, Unger M, et al. A proposed classification system of central airway stenosis. Eur Respir J. 2007;30:7–12.CrossRef
2.
go back to reference Ernst A, Feller-Kopman D, Becker HD, et al. Central airway obstruction. Am J Respir Crit Care Med. 2004;169:1278–97.CrossRef Ernst A, Feller-Kopman D, Becker HD, et al. Central airway obstruction. Am J Respir Crit Care Med. 2004;169:1278–97.CrossRef
3.
go back to reference Murgu SD, Egressy K, Laxmanan B, et al. Central airway obstruction: benign strictures, tracheobronchomalacia, and malignancy-related obstruction. Chest. 2016;150:426–41.CrossRef Murgu SD, Egressy K, Laxmanan B, et al. Central airway obstruction: benign strictures, tracheobronchomalacia, and malignancy-related obstruction. Chest. 2016;150:426–41.CrossRef
4.
go back to reference Barros Casas D, Fernández-Bussy S, Folch E, et al. Non-malignant central airway obstruction. Arch Bronconeumol. 2014;50:345–54.CrossRef Barros Casas D, Fernández-Bussy S, Folch E, et al. Non-malignant central airway obstruction. Arch Bronconeumol. 2014;50:345–54.CrossRef
5.
go back to reference Krajc T, Janik M, Benej R, et al. Urgent segmental resection as the primary strategy in management of benign tracheal stenosis. A single center experience in 164 consecutive cases. Interact Cardiovasc Thorac Surg. 2009;9:983–9.CrossRef Krajc T, Janik M, Benej R, et al. Urgent segmental resection as the primary strategy in management of benign tracheal stenosis. A single center experience in 164 consecutive cases. Interact Cardiovasc Thorac Surg. 2009;9:983–9.CrossRef
6.
go back to reference Dalar L, Karasulu L, Abul Y, et al. Bronchoscopic treatment in the management of benign tracheal stenosis: choices for simple and complex tracheal stenosis. Ann Thorac Surg. 2016;101:1310–7.CrossRef Dalar L, Karasulu L, Abul Y, et al. Bronchoscopic treatment in the management of benign tracheal stenosis: choices for simple and complex tracheal stenosis. Ann Thorac Surg. 2016;101:1310–7.CrossRef
7.
go back to reference Mahmood K, Wahidi MM, Thomas S, et al. Therapeutic bronchoscopy improves spirometry, quality of life, and survival in central airway obstruction. Respiration. 2015;89:404–13.CrossRef Mahmood K, Wahidi MM, Thomas S, et al. Therapeutic bronchoscopy improves spirometry, quality of life, and survival in central airway obstruction. Respiration. 2015;89:404–13.CrossRef
8.
go back to reference Liang W, Hu P, Guo W, et al. Appropriate treatment sessions of flexible bronchoscopic balloon dilation for patients with nonmalignant central airway stenosis. Ther Adv Respir Dis. 2019;13:1753466619831966.CrossRef Liang W, Hu P, Guo W, et al. Appropriate treatment sessions of flexible bronchoscopic balloon dilation for patients with nonmalignant central airway stenosis. Ther Adv Respir Dis. 2019;13:1753466619831966.CrossRef
9.
go back to reference Smith ME, Elstad M. Mitomycin C and the endoscopic treatment of laryngotracheal stenosis: are two applications better than one? Laryngoscope. 2009;119:272–83.CrossRef Smith ME, Elstad M. Mitomycin C and the endoscopic treatment of laryngotracheal stenosis: are two applications better than one? Laryngoscope. 2009;119:272–83.CrossRef
10.
go back to reference Sratakos G, Chiotis D, Zisis C, et al. Long-term outcomes of patients with benign tracheal stenosis after multidisciplinary management. Eur Respir J. 2011;38(Suppl 55):p613. Sratakos G, Chiotis D, Zisis C, et al. Long-term outcomes of patients with benign tracheal stenosis after multidisciplinary management. Eur Respir J. 2011;38(Suppl 55):p613.
11.
go back to reference Galluccio G, Lucantoni G, Battistoni P, et al. Interventional endoscopy in the management of benign tracheal stenoses: definitive treatment at long-term follow-up. Eur J Cardiothorac Surg. 2009;35:429–33 (discussion 933-4).CrossRef Galluccio G, Lucantoni G, Battistoni P, et al. Interventional endoscopy in the management of benign tracheal stenoses: definitive treatment at long-term follow-up. Eur J Cardiothorac Surg. 2009;35:429–33 (discussion 933-4).CrossRef
12.
go back to reference Myer CM 3rd, O’Connor DM, Cotton RT. Proposed grading system for subglottic stenosis based on endotracheal tube sizes. Ann Otol Rhinol Laryngol. 1994;103:319–23.CrossRef Myer CM 3rd, O’Connor DM, Cotton RT. Proposed grading system for subglottic stenosis based on endotracheal tube sizes. Ann Otol Rhinol Laryngol. 1994;103:319–23.CrossRef
13.
go back to reference Okiror L, Jiang L, Oswald N, et al. Bronchoscopic management of patients with symptomatic airway stenosis and prognostic factors for survival. Ann Thorac Surg. 2015;99:1725–30.CrossRef Okiror L, Jiang L, Oswald N, et al. Bronchoscopic management of patients with symptomatic airway stenosis and prognostic factors for survival. Ann Thorac Surg. 2015;99:1725–30.CrossRef
14.
go back to reference Morais A, Fernandes G, Magalhães A. The role of interventional bronchoscopy in the management of post-intubation tracheal stenosis: a 20-year experience. Pulmonology. 2019;S2531–0437(19):30222–3. Morais A, Fernandes G, Magalhães A. The role of interventional bronchoscopy in the management of post-intubation tracheal stenosis: a 20-year experience. Pulmonology. 2019;S2531–0437(19):30222–3.
15.
go back to reference Gadkaree SK, Pandian V, Best S, et al. Laryngotracheal stenosis: risk factors for tracheostomy dependence and dilation interval. Otolaryngol Head Neck Surg. 2017;156:321–8.CrossRef Gadkaree SK, Pandian V, Best S, et al. Laryngotracheal stenosis: risk factors for tracheostomy dependence and dilation interval. Otolaryngol Head Neck Surg. 2017;156:321–8.CrossRef
16.
go back to reference Giovacchini CX, Kessler ER, Merrick CM, et al. Clinical and radiographic predictors of successful therapeutic bronchoscopy for the relief of malignant central airway obstruction. BMC Pulm Med. 2019;19:219.CrossRef Giovacchini CX, Kessler ER, Merrick CM, et al. Clinical and radiographic predictors of successful therapeutic bronchoscopy for the relief of malignant central airway obstruction. BMC Pulm Med. 2019;19:219.CrossRef
17.
go back to reference Hoffmann RF, Zarrintan S, Brandenburg SM, et al. Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cells. Respir Res. 2013;14(1):97.CrossRef Hoffmann RF, Zarrintan S, Brandenburg SM, et al. Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cells. Respir Res. 2013;14(1):97.CrossRef
18.
go back to reference Yang J, Yu HM, Zhou XD, et al. Cigarette smoke induces mucin hypersecretion and inflammatory response through the p66shc adaptor protein-mediated mechanism in human bronchial epithelial cells. Mol Immunol. 2016;69:86–98.CrossRef Yang J, Yu HM, Zhou XD, et al. Cigarette smoke induces mucin hypersecretion and inflammatory response through the p66shc adaptor protein-mediated mechanism in human bronchial epithelial cells. Mol Immunol. 2016;69:86–98.CrossRef
19.
go back to reference Gadkaree SK, Gelbard A, Best SR, et al. Outcomes in bilateral vocal fold immobility: a retrospective cohort analysis. Otolaryngol Head Neck Surg. 2018;18:194599818800462. Gadkaree SK, Gelbard A, Best SR, et al. Outcomes in bilateral vocal fold immobility: a retrospective cohort analysis. Otolaryngol Head Neck Surg. 2018;18:194599818800462.
20.
go back to reference Ost DE, Ernst A, Grosu HB, et al. Therapeutic bronchoscopy for malignant central airway obstruction: success rates and impact on dyspnea and quality of life. Chest. 2015;147(5):1282–98.CrossRef Ost DE, Ernst A, Grosu HB, et al. Therapeutic bronchoscopy for malignant central airway obstruction: success rates and impact on dyspnea and quality of life. Chest. 2015;147(5):1282–98.CrossRef
21.
go back to reference Wang T, Zhang J, Qiu XJ, et al. Scarring airway stenosis in Chinese adults: characteristics and interventional bronchoscopy treatment. Chin Med J (Engl). 2018;131:276–81.CrossRef Wang T, Zhang J, Qiu XJ, et al. Scarring airway stenosis in Chinese adults: characteristics and interventional bronchoscopy treatment. Chin Med J (Engl). 2018;131:276–81.CrossRef
22.
go back to reference Rahman NA, Fruchter O, Shitrit D, et al. Flexible bronchoscopic management of benign tracheal stenosis: long term follow-up of 115 patients. J Cardiothorac Surg. 2010;5:2.CrossRef Rahman NA, Fruchter O, Shitrit D, et al. Flexible bronchoscopic management of benign tracheal stenosis: long term follow-up of 115 patients. J Cardiothorac Surg. 2010;5:2.CrossRef
23.
go back to reference Global tuberculosis report 2017. Geneva: World Health Organization; 2017. Global tuberculosis report 2017. Geneva: World Health Organization; 2017.
24.
go back to reference Cataneo DC, Ximenes AMG, Cataneo AJM. Mitomycin C in the endoscopic treatment of tracheal stenosis: a prospective cohort study. J Bras Pneumol. 2018;44:486–90.CrossRef Cataneo DC, Ximenes AMG, Cataneo AJM. Mitomycin C in the endoscopic treatment of tracheal stenosis: a prospective cohort study. J Bras Pneumol. 2018;44:486–90.CrossRef
25.
go back to reference Hseu AF, Benninger MS, Haffey TM, et al. Subglottic stenosis: a ten-year review of treatment outcomes. Laryngoscope. 2014;124:736–41.CrossRef Hseu AF, Benninger MS, Haffey TM, et al. Subglottic stenosis: a ten-year review of treatment outcomes. Laryngoscope. 2014;124:736–41.CrossRef
26.
go back to reference Nair S, Nilakantan A, Sood A, et al. Challenges in the management of laryngeal stenosis. Indian J Otolaryngol Head Neck Surg. 2016;68:294–9.CrossRef Nair S, Nilakantan A, Sood A, et al. Challenges in the management of laryngeal stenosis. Indian J Otolaryngol Head Neck Surg. 2016;68:294–9.CrossRef
27.
go back to reference Thurnher D, Moukarbel RV, Novak CB, et al. The glottis and subglottis: an otolaryngologist’s perspective. Thorac Surg Clin. 2007;17:549–60.CrossRef Thurnher D, Moukarbel RV, Novak CB, et al. The glottis and subglottis: an otolaryngologist’s perspective. Thorac Surg Clin. 2007;17:549–60.CrossRef
28.
go back to reference Gelbard A, Francis DO, Sandulache VC, et al. Causes and consequences of adult laryngotracheal stenosis. Laryngoscope. 2015;125:1137–43.CrossRef Gelbard A, Francis DO, Sandulache VC, et al. Causes and consequences of adult laryngotracheal stenosis. Laryngoscope. 2015;125:1137–43.CrossRef
29.
go back to reference Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141–212.CrossRef Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141–212.CrossRef
30.
go back to reference Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805–12.CrossRef Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805–12.CrossRef
31.
go back to reference Oshodi A, Dysart K, Cook A, et al. Airway injury resulting from repeated endotracheal intubation: possible prevention strategies. Pediatr Crit Care Med. 2011;12:e34–9.CrossRef Oshodi A, Dysart K, Cook A, et al. Airway injury resulting from repeated endotracheal intubation: possible prevention strategies. Pediatr Crit Care Med. 2011;12:e34–9.CrossRef
32.
go back to reference Ghazizadeh M, Tosa M, Shimizu H, et al. Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol. 2007;127:98–105.CrossRef Ghazizadeh M, Tosa M, Shimizu H, et al. Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol. 2007;127:98–105.CrossRef
33.
go back to reference Li ZI, Chung AC, Zhou L, et al. C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice. Lab Invest. 2011;91(6):837–51.CrossRef Li ZI, Chung AC, Zhou L, et al. C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice. Lab Invest. 2011;91(6):837–51.CrossRef
34.
go back to reference Zhang R, Zhang YY, Huang XR, et al. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease. Hypertension. 2010;55(4):953–60.CrossRef Zhang R, Zhang YY, Huang XR, et al. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease. Hypertension. 2010;55(4):953–60.CrossRef
35.
go back to reference Zhang J, Wang T, Wang J, et al. Effect of three interventional bronchoscopic methods on tracheal stenosis and the formation of granulation tissues in dogs. Chin Med J (Engl). 2010;123:621–7. Zhang J, Wang T, Wang J, et al. Effect of three interventional bronchoscopic methods on tracheal stenosis and the formation of granulation tissues in dogs. Chin Med J (Engl). 2010;123:621–7.
36.
go back to reference Verkindre C, Brichet A, Maurage CA, et al. Morphological changes induced by extensive endobronchial electrocautery. Eur Respir J. 1999;14:796–9.CrossRef Verkindre C, Brichet A, Maurage CA, et al. Morphological changes induced by extensive endobronchial electrocautery. Eur Respir J. 1999;14:796–9.CrossRef
37.
go back to reference Dunlap DG, Ravenel J, Sechrist J, et al. Interventional therapies for central airways. J Thorac Imaging. 2019;34:W49–59.CrossRef Dunlap DG, Ravenel J, Sechrist J, et al. Interventional therapies for central airways. J Thorac Imaging. 2019;34:W49–59.CrossRef
38.
go back to reference Rea F, Callegaro D, Loy M, et al. Benign tracheal and laryngotracheal stenosis: surgical treatment and results. Eur J Cardiothorac Surg. 2002;22:352–6.CrossRef Rea F, Callegaro D, Loy M, et al. Benign tracheal and laryngotracheal stenosis: surgical treatment and results. Eur J Cardiothorac Surg. 2002;22:352–6.CrossRef
39.
go back to reference DiBardino DM, Lanfranco AR, Haas AR. Bronchoscopic cryotherapy. Clinical applications of the cryoprobe, cryospray, and cryoadhesion. Ann Am Thorac Soc. 2016;13:1405–15.CrossRef DiBardino DM, Lanfranco AR, Haas AR. Bronchoscopic cryotherapy. Clinical applications of the cryoprobe, cryospray, and cryoadhesion. Ann Am Thorac Soc. 2016;13:1405–15.CrossRef
40.
go back to reference Ko PJ, Liu CY, Wu YC, et al. Granulation formation following tracheal stenosis stenting: influence of stent position. Laryngoscope. 2009;119:2331–6.CrossRef Ko PJ, Liu CY, Wu YC, et al. Granulation formation following tracheal stenosis stenting: influence of stent position. Laryngoscope. 2009;119:2331–6.CrossRef
41.
go back to reference Shin JH, Song HY, Shim TS. Management of tracheobronchial strictures. Cardiovasc Intervent Radiol. 2004;27:314–24.CrossRef Shin JH, Song HY, Shim TS. Management of tracheobronchial strictures. Cardiovasc Intervent Radiol. 2004;27:314–24.CrossRef
Metadata
Title
Long-term prognostic factors of clinical success after interventional bronchoscopy in patients with scarring central airway stenosis
Authors
Kunyan Sun
Hong Zhang
Wei Zhang
Yuan Cheng
Guangfa Wang
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Bronchoscopy
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01434-5

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.